Search by tag «eJHaem» 1 results

• GEROPHARM and ITMO Test New Treatment for Blood Disease

  Public health scientists from ITMO, in collaboration with the biotech company GEROPHARM and other Russian colleagues, have recently completed the third testing stage of a new medicine for patients with immune thrombocytopenia. In this condition, the body mistakenly destroys its own thrombocytes. The new treatment is described in a paper published in eJHaem.

  22.08.2025